ProjectENDIT: Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS

Sponsor
H. Lee Moffitt Cancer Center and Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05746442
Collaborator
National Cancer Institute (NCI) (NIH), University of Oklahoma (Other), M.D. Anderson Cancer Center (Other)
800
3
2
25.8
266.7
10.3

Study Details

Study Description

Brief Summary

The goal of this research study is to test how well an automated text messaging smoking treatment program helps smokers with HIV quit smoking.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Smartphone-delivered Automated Messaging
  • Drug: Nicotine patch
  • Behavioral: Brief Advice to Quit and Smoking Cessation Self Help Materials
  • Behavioral: Diet Assessment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS (Project END-IT)
Actual Study Start Date :
Jan 5, 2023
Anticipated Primary Completion Date :
Mar 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard Care Group

Participants will receive brief advice and education materials to quit smoking along with brief weekly assessments to be completed on a smartphone. They will also receive a 8 week supply of of nicotine replacement therapy in the form of nicotine patches.

Drug: Nicotine patch
Participants will be provided with a 8 week supply of nicotine patches

Behavioral: Brief Advice to Quit and Smoking Cessation Self Help Materials
Participants will receive self-help materials from Khmer Quit Now, a national smoking cessation campaign in Cambodia

Behavioral: Diet Assessment
Participants will be asked to complete brief weekly smartphone assessments about their diet for a 26-week period

Experimental: Automated Messaging Treatment Group

Participants will receive brief advice and education materials to quit smoking, along with brief weekly assessments and an interactive phone-based treatment program delivered on a smartphone. They will also receive a 8 week supply of of nicotine replacement therapy in the form of nicotine patches.

Behavioral: Smartphone-delivered Automated Messaging
An interactive smartphone based intervention will provide weekly smoking-related assessments and personalized automated messages designed to increase motivation, self-efficacy, use of coping skills, social support and to reduce nicotine withdrawal symptoms and stress for a 26 week period.

Drug: Nicotine patch
Participants will be provided with a 8 week supply of nicotine patches

Behavioral: Brief Advice to Quit and Smoking Cessation Self Help Materials
Participants will receive self-help materials from Khmer Quit Now, a national smoking cessation campaign in Cambodia

Outcome Measures

Primary Outcome Measures

  1. Self Reported 7 Day Abstinence Smoking Status [12 Month Follow-Up]

    Participants will self report 7-day abstinence smoking status

  2. Smoking Status by Expired Carbon Monoxide [12 Month Follow-up]

    Investigators will use a CO monitor to verify smoking status biochemically

Secondary Outcome Measures

  1. Self Reported 7 Day Abstinence Smoking Status at 3 Months [At 3 Months]

    Participants will self report 7-day abstinence smoking status

  2. Smoking Status by Expired Carbon Monoxide at 3 Months [At 3 Months]

    Investigators will use a CO monitor to verify smoking status biochemically

  3. Self Reported 7 Day Abstinence Smoking Status at 6 Months [At 6 Months]

    Participants will self report 7-day abstinence smoking status

  4. Smoking Status by Expired Carbon Monoxide at 6 Months [At 6 Months]

    Investigators will use a CO monitor to verify smoking status biochemically

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    1. being aged ≥18 years
    1. being HIV-positive
    1. self-reporting as a current combustible cigarette smoker (smoked ≥100 cigarettes in lifetime and currently smoke ≥1 cigarettes/day)
    1. willing to set a date for a quit attempt within 2 weeks of study enrollment
    1. being able to provide written informed consent to participate
    1. being able to read Khmer (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form
Exclusion Criteria:
    1. history of a medical condition that precludes use of nicotine replacement therapy
    1. physician/clinician deemed ineligible to participate based on medical or psychiatric condition
    1. enrolled in another cessation program or use of other cessation medications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National AIDS Authority Phnom Penh Cambodia
2 National Center for HIV/AIDS, Dermatology and STD Phnom Penh Cambodia
3 National Institute of Public Health Phnom Penh Cambodia

Sponsors and Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute
  • National Cancer Institute (NCI)
  • University of Oklahoma
  • M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Damon Vidrine, Dr.PH, Moffitt Cancer Center
  • Principal Investigator: Thanh Bui, Dr.PH, Phnom Penh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT05746442
Other Study ID Numbers:
  • MCC-21528
  • U01CA261598
First Posted:
Feb 27, 2023
Last Update Posted:
Feb 27, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 27, 2023